Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicament for treating chronic obstructive emphysema and chronic pulmonary heart disease

A technology for cor pulmonale and chronic obstructive disease, applied in the drug field of chronic obstructive emphysema and cor pulmonale, which can solve the high recurrence rate and unsatisfactory effect. , high mortality and other issues, to achieve the effect of strong anti-relapse ability, lower treatment costs, and reasonable compatibility

Inactive Publication Date: 2008-02-27
江景秀
View PDF0 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, there is no specific medicine for the treatment of chronic obstructive emphysema and pulmonary heart disease. Most of them are treated with anti-inflammatory, cough, asthma or heart disease drugs. The effect is not ideal, the recurrence rate is high, and the mortality rate is high.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Embodiment 1: a kind of medicine for the treatment of chronic obstructive emphysema, cor pulmonale, is made up of following natural raw materials taking weight part as unit: 15 parts of Vitex chrysalis, 5 parts of almond, 12 parts of Pinellia chinensis, 10 parts of Schisandra chinensis 8 parts of Chuan Fritillaria, 12 parts of Chuanxiong, 15 parts of Salvia, 5 parts of Campanulaceae, 8 parts of Morus Alba, 10 parts of Coltsfoot, 15 parts of Astragalus, 10 parts of Codonopsis, 12 parts of Ginkgo, 20 parts of Trichosanthes, 10 Atractylodes 15 parts of angelica, 10 parts of poria cocos, 10 parts of honeysuckle, 5 parts of coptis, 10 parts of golden buckwheat, 9 parts of windproof, 5 parts of licorice, 12 parts of dried peach, 10 parts of jujube seed, 6 parts of pearl, the above components Grind and pulverize together, pass through a 100-mesh sieve to make the required drug dosage form, patients take 8-12 grams each time, twice a day, take it after meals, children reduce it ...

Embodiment 2

[0030] Embodiment 2: The preparation and administration method of the medicine of this embodiment are the same as that of Example 1, and the similarities will not be repeated. The difference is that a kind of medicine for the treatment of chronic obstructive emphysema and cor pulmonale consists of The following natural raw materials are composed of parts by weight: 25 parts of Vitex japonica, 15 parts of almond, 20 parts of Pinellia chinensis, 35 parts of Schisandra chinensis, 45 parts of Chuan Fritillaria, 20 parts of Rhizoma Chuanxiong, 30 parts of Salvia miltiorrhiza, 15 parts of platycodon grandiflorum, and 30 parts of Cortex Mori 18 parts of Coltsfoot, 30 parts of Astragalus, 20 parts of Codonopsis, 20 parts of Ginkgo, 35 parts of Trichosanthes, 20 parts of Atractylodes Rhizoma, 25 parts of Angelica, 20 parts of Poria, 30 parts of Honeysuckle, 15 parts of Coptidis, 30 parts of Golden Buckwheat, and Fangfeng 20 parts, 20 parts of licorice, 30 parts of dried peaches, 30 part...

Embodiment 3

[0031] Embodiment 3: The preparation and administration method of the medicine of this embodiment are the same as that of Example 1, and the similarities will not be repeated. The difference is that a kind of medicine for the treatment of chronic obstructive emphysema and cor pulmonale consists of The composition of the following natural raw materials in parts by weight: 15 parts of Vitex japonica, 10 parts of almond, 15 parts of Pinellia chinensis, 10 parts of Schisandra chinensis, 10 parts of Chuan Fritillaria, 15 parts of Rhizoma Chuanxiong, 25 parts of Salvia miltiorrhiza, 10 parts of platycodon grandiflorum, 15 parts of Morus alba 15 parts of Coltsfoot, 20 parts of Astragalus, 15 parts of Codonopsis, 15 parts of Ginkgo, 30 parts of Trichosanthes, 15 parts of Atractylodes Rhizoma, 20 parts of Angelica, 15 parts of Poria, 15 parts of Honeysuckle, 12 parts of Coptis chinensis, 15 parts of Golden Buckwheat, and Fangfeng 15 parts, 5 parts of licorice, 20 parts of dried peaches,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a Chinese medicament for treating chronic obstructive emphysema and pulmonary heart disease, which comprises the following crude herbal materials (by weight portion): chastetree fruit 15-25 parts, apricot kernel 5-15 parts, pinellia tuber 12-20 parts, schisandra fruit 10-35 parts, Sichuan fritillary bulb 8-35 parts, rhizome of Sichuan lovage 12-20 parts, red sage root 15-30 parts, root of balloonflower 5-15 parts, mulberry bark 8-30 parts, coltsfoot flower 10-18 parts, astragalus root 15-30 parts, pilose asiabell root 10-40 parts, ginkgo nut 12-20 parts, trichosanthes anguina 20-35 parts, white atractylodes rhizome 10-20 parts, Chinese angelica root 15-35 parts, poria cocos wolf 10-30 parts, honeysuckle flower 10-30 parts, coptis root 5-15 parts, golden buckwheat rhizome 10-30 parts, ledebouriella root 9-30 parts, licorice root 5-20 parts, dried peach 12-30 parts, wild or spiny jujuba seed 10-30 parts, pearl 6-15 parts.

Description

Technical field: [0001] The invention relates to a medicine using natural Chinese medicinal materials as raw materials, in particular to a medicine for treating chronic obstructive emphysema and cor pulmonale, belonging to the field of traditional Chinese medicine. Background technique: [0002] Chronic obstructive emphysema, cor pulmonale, referred to as "pulmonary heart disease" for short, is due to chronic disease of the lungs, thorax, or pulmonary artery, resulting in increased pulmonary circulatory resistance, pulmonary arterial hypertension, and then causing right ventricular hypertrophy, enlargement, or right heart failure heart disease. The disease develops slowly. Clinically, in addition to the various symptoms and signs of the original lung and chest diseases, the main signs of lung and cardiac insufficiency and other organ damage appear gradually. The clinical manifestations are: (1) Primary symptoms of the respiratory tract: Chronic bronchitis and emphysema are ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/8888A61K9/14A61K9/16A61K9/20A61K9/48A61P11/00A61P9/00A61K35/56A61K35/618
Inventor 江景秀冯舸江枫
Owner 江景秀
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com